Skip to main content

Table 2 Antimicrobial sensitivity profile for Pseudomonas aeruginosa from a paediatric patient over an 8 year period

From: A case of failed eradication of cystic fibrosis-related sinus colonisation by Pseudomonas aeruginosa

  CLSI Guidelines EUCAST Guidelines
  Disk content (μg) 2006 2007 2008 2010 2011 2012 Disk content (μg) 2013 2014
   11/8 23/8 6/8 5/5 14/12 22/4 10/4   26/3 6/6 30/9 20/12 23/1 23/1a 11/9a
Drug                 
 Ofloxacin 5 S S NT NT NT NT NT 0 NT NT NT NT NT NT NT
 Pipercillin/ Tazobactum 100/10 S S S S S S S 36 S S S S S R S
 Ceftazidime 30 S S S S S S S 10 S S S S S S S
 Tobramycin 10 S S S S S S S 10 S S S S S S S
 Ciprofloxacin 5 NT S NT S S S S 5 S S S S S S S
 Amikacin 30 NT S NT NT NT NT NT 30 NT NT NT NT NT NT NT
 Aztreoman 30 NT S NT NT NT NT S 30 S I I I I I I
 Colistin (E-Test) 10 NT S NT NT NT NT NT 10 NT NT S S S S S
 Imipenem 10 NT S NT NT NT NT NT 10 NT NT NT NT NT NT NT
 Meropenem 10 NT S S S S S S 10 S S S S S S S
  1. S Susceptible, I Intermediate, R Resistant and NT Not Tested
  2. aP. aeruginosa isolated from antral washing